STATE STREET CORP - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 37 filers reported holding INMUNE BIO INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2023$307,547
-24.7%
44,9630.0%0.00%
Q2 2023$408,264
+40.6%
44,9630.0%0.00%
Q1 2023$290,461
-49.1%
44,963
-50.0%
0.00%
Q4 2022$570,130
+104.3%
89,926
+100.0%
0.00%
Q3 2022$279,000
-29.7%
44,9630.0%0.00%
Q2 2022$397,000
+25.2%
44,963
+19.4%
0.00%
Q1 2022$317,000
-8.1%
37,663
+11.4%
0.00%
Q4 2021$345,000
-35.9%
33,816
+22.0%
0.00%
Q3 2021$538,000
-12.1%
27,716
-20.4%
0.00%
Q2 2021$612,00034,8160.00%
Other shareholders
INMUNE BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Westside Investment Management, Inc. 37,105$239,7030.07%
QUADRANT CAPITAL GROUP LLC 60,000$387,6000.04%
Janney Montgomery Scott LLC 239,448$1,5470.01%
Financial Advocates Investment Management 11,500$74,2900.01%
MAI Capital Management 19,643$126,8940.00%
VALLEY NATIONAL ADVISERS INC 1,000$80.00%
NORTHERN TRUST CORP 20,297$131,1190.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 9,036$58,3730.00%
GEODE CAPITAL MANAGEMENT, LLC 143,657$928,0240.00%
View complete list of INMUNE BIO INC shareholders